Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

NCT05085275

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron Deficiency, +25 more
Locations
  • Arkansas Nephrology & Hypertension Clinic Pine Bluff, Arkansas, United States
  • Balboa Research SMO Chula Vista, California, United States
  • Balboa Research SMO El Centro, California, United States
  • Balboa Research SMO Escondido, California, United States
View all 23 locations
View Trial Details
Completed

Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

NCT02136134

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Stamford, Connecticut, United States
  • Jacksonville, Florida, United States
View all 105 locations
View Trial Details
Completed

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib

NCT00777036

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institution - 0005 Phoenix, Arizona, United States
  • Phoenix Children'S Hospital Phoenix, Arizona, United States
  • Jonathan Jaques Children'S Cancer Center Long Beach, California, United States
View all 174 locations
View Trial Details
Completed

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

NCT03952039

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Local Institution - 103 Darlinghurst, New South Wales, Australia
  • Local Institution - 101 Adelaide, South Australia, Australia
  • Local Institution - 105 Box Hill, Victoria, Australia
  • Local Institution - 102 Langwarrin, Victoria, Australia
View all 107 locations
View Trial Details
Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details

Related conditions